Category Archives: Cancer Care Tips

Alternative Cancer Treatment, Cancer Care Tips, Cancer Research, Cancer Survivors

New Support for Cancer Treatment During Pregnancy

Happy mother, father and daughter in the park
Keeping Baby Safe Even With Cancer

Patients who receive a cancer diagnosis have some difficult choices to make regarding treatments such as chemotherapy or immuno-oncology. Pregnant women have two lives to consider, placing additional weight on their decision for cancer treatment. Is there any option that will not pose significant risk to the fetus?

Some doctors recommend erring on the side of caution, suggesting a preterm delivery or even termination. The results of a study that was presented at the recent European Cancer Conference in Vienna show that cancer treatment may not necessarily interfere with a healthy, full-term pregnancy.

Dr. Frédéric Amant of the Katholieke Universiteit Leuven in Belgium was the lead author of the study, which involved more than 100 children born to women who underwent cancer treatment within the last two trimesters of their pregnancy. Results revealed no difference in cardiac and cognitive functions between these children and those in the control group.

Since birth defects are most likely to occur during the first trimester, none of the women participating in the study received treatment during that period. Premature delivery was found to have a greater impact on fetal development than cancer treatment. Each additional week in the womb added two points to a child’s score on the Bayley Scales of Infant Development, which was used in conjunction with a neurological exam to measure results.

Our non-toxic immuno-oncology therapies at Issels® are personalized to account for lifestyle and other elements of your individual situation. Visit our website for more information about our innovative, state-of-the-art treatments as well as testimonials from our patients.

Alternative Cancer Treatment, Cancer Care Tips, Cancer Research, News

New Advance in Pancreatic Cancer Treatment Just in Time for Pancreatic Cancer Awareness Month

New Understanding of Pancreatic Cancer
New Understanding of Pancreatic Cancer

Pancreatic cancer can be difficult to treat with conventional methods, such as chemotherapy. With this form of cancer on the rise, researchers have been working on developing other forms of treatment that might be more effective. Recent developments have led to a new type of treatment for pancreatic cancer that is showing promise as a highly successful way to boost survival rates.

Irreversible Electroporation

Researchers have come up with a treatment that delivers small yet strong electrical bursts that destroy pancreatic cancer cells, which is known as irreversible electroporation (IRE). These electrical bursts create holes in the cells, which leads them to die off. The use of this type of treatment has been associated with a survival rate that nearly doubles for those who also undergo a traditional form of treatment, such as chemo-radiotherapy. IRE is able to affect cancer cells while leaving noncancerous tissue around those cells unharmed, which can lower the risk of side effects and complications.

Researchers are planning on testing IRE in clinical trials to better determine its effectiveness for those with pancreatic cancer. The current study that was conducted involved 200 adults who were diagnosed with Stage III pancreatic cancer. While roughly half of those participants ended up with complications after undergoing IRE, these effects were considered minimal. Researchers found that the average survival rate for study participants was two years, although some lived for up to seven years.

If you would like more information on our non-toxic forms of treatment for pancreatic cancer, please contact the Issels® Center for Integrative Immuno-Oncology. We offer immunotherapy and other types of alternative cancer treatments.

Alternative Cancer Treatment, Cancer Care Tips, Cancer Research, Stage Four Cancer Treatment

What to Understand about Metastatic Cancer

Understanding Stage IV
Understanding Stage IV

Have you heard reference to the term “metastatic cancer” but you’re unsure what it means? It may sound like a technical term, but it’s a relatively straightforward concept. Here are some facts to help demystify the issue.

Metastatic cancer is also called “stage IV” or “advanced”

All three terms refer to cancer that has spread from its original location to other parts of the body. Metastasis is the process by which cancer cells migrate via the blood or lymph system.

Metastatic tumors are treated the same as the original tumors

The tumors are called by the same name and treated with the same protocols as the primary cancer. If the original location cannot be determined, it’s considered to be carcinoma of unknown primary origin, or CUP. The patient undergoes a series of diagnostic tests to help doctors zero in on possible locations of the main tumor as well as appropriate courses of treatment.

Different forms of cancer are more likely to travel to particular areas

For example, breast cancer most commonly metastasizes to the lungs or bones. In addition, stage IV cancer may spread to one or several additional locations.

Metastatic cancer can be successfully treated

While the spread of tumors is a serious development, medical advances have made significant improvements in life expectancy for stage IV patients. Ongoing tests and studies continue to make breakthroughs in effective protocols.

Our state-of-the-art, non-toxic immunotherapy protocols boost your body’s own ability to fight cancer at any stage. Contact us to learn more about our comprehensive, individualized treatment programs at Issels®.

Cancer Care Tips, Cancer Research, Living with Cancer

Incidence of Lung Cancer in Non-Smokers Rises to 15%

Lung Cancer On The Decline
Rise in Lung Cancer in Non Smokers

Smoking tobacco has long been a known risk factor for lung cancer. Surprisingly, as smoking rates have declined, non-smokers have accounted for a higher percentage of lung cancer cases. In addition, these patients are more likely to be women.

Data comes from studies in Great Britain and the United States involving non-small cell cancer, which constitutes 85 to 90 percent of all lung cancer cases. This type is aggressive and usually detected at a later stage, particularly in non-smokers who are not screened as often due to fewer risk factors.

Over a seven-year period, British researchers discovered that the percentage of never-smokers with lung cancer more than doubled from 13 percent to 28 percent. Subjects included 2,170 patients between 2008 and 2014.

Their American counterparts had similar results in a study of lung cancer patients between 1990 and 2013. According to lead researcher Dr. Lorraine Pelosof, nine percent of non-small cell patients between 1990 and 1995 were never-smokers. In the period of 2011-2013, the percentage had grown to nearly 15 percent.

At present, researchers are stumped as to the reason for these increases, or why women are more susceptible. Ongoing studies are focusing on genetic risk and family history as possible causes in the absence of tobacco use. Dr. Pelosof also commented on the need to confirm her team’s findings, noting limitations such as the smoking history of subjects being self-reported.

Our Issels® immuno-oncology protocols take into account your lifestyle, genetic history, environment and other factors that affect your case. The result is a personalized, non-toxic course of treatment that addresses your specific needs. Visit our website to learn more.

Breast Cancer, Cancer Care Tips, Living with Cancer

Men Can Get Breast Cancer Too

Men can get breast cancer too!
Men can get breast cancer too!

Although rare, breast cancer does affect men. Roughly 1 percent of all cases occur in men, meaning a few thousand U.S. males are diagnosed with breast cancer every year. As with female breast cancer, the male form typically begins with lumps and progresses if untreated.

The way men seek diagnosis and treatment has evolved over the years. As awareness campaigns and media spotlight increased the visibility of the disease, a larger number of men are getting screened and treated for breast cancer risk factors.

The Hamilton (Ontario) Spectator recently reported a trend of men electing to undergo a double mastectomy as treatment — and as a preventive measure upon discovering genetic risk factors. A recent JAMA Surgery study found that contralateral prophylactic mastectomy surgery had risen from 3 percent to 5.6 percent among male patients with one tumor.

“A Culture of Awareness”

The increase in male patients receiving mastectomies comes on the heels of other recent reports about changes in the way breast cancer is diagnosed and treated. Some research has suggested that frequent mammograms in women had led to over-diagnosis.

The preventive double mastectomy option — highlighted by actress Angelina Jolie’s treatment due to BRCA1 gene mutation — has sparked debate about elective surgery conducted based on risk factors rather than the presence of cancer.

Authors of the JAMA Surgery have concluded that men should carefully weigh all options when facing information about breast cancer risks and cancer treatment options. Tissue removal may only be beneficial for some patients.

For more information about innovative cancer treatments, contact us at Issels®. We provide non-toxic therapies and immunotherapy, with an emphasis on personalized care.

Alternative Cancer Treatment, Cancer Care Tips, Cancer Research, Immuno-Oncology

Flavonoids Found in Fruits and Vegetables May Cut Breast Cancer Risk in Older Women

Eat Fruit To Reduce Breast Cancer?
Eat Fruit To Reduce Breast Cancer?

Here’s another reason to start eating right: a new group of scientists are looking more closely into specific molecules within fruits and vegetables called flavonoids, which show promise in reducing the risk of breast cancer. Flavonoids are molecules within fruits and vegetables found to have health and antioxidant benefits. One type of flavonoid in particular, called luteolin, is being studied for its significant benefit during hormone replacement therapy in women.

Luteolin is a plant compound that has many biological benefits such as anti-inflammation, anti-allergy and anticancer. It’s used in Chinese traditional medicine for treating multiple illnesses such as hypertension, inflammatory disorders, as well as cancer. Luteolin acts by suppressing cancer cell survival pathways, and inducing other pathways that promote cancer cell suppression.

The researchers sought to uncover luteolin’s effect on breast cancer cells and animal test subjects. They observed a reduction in tumor growth and regression in the cancer cells as luteolin blocked the cells from progressing, similar to another flavonoid called apigenin. According to the researchers, luteolin is more effective, because it has a low probability of metabolizing into a toxic compound.

The researchers stated that luteolin can be effective if it’s injected directly into the blood stream, and may one day in the future be able to be used as an IV compound.

There is still much to be learned about the many valuable components that can be derived from fruits and vegetables, such as flavonoids, which could one day lead to the discovery of new medicines. That’s a future worth looking forward to. For more information on cancer care and non-toxic treatment, contact Issels®, your Integrative Immuno-Oncology experts.